A novel imaging biomarker is able to detect inflammation of fatty tissue surrounding the coronary arteries using computed tomography.
Researchers also say the non-invasive approach can predict all-cause and cardiac mortality.
Developed by researchers at the Cleveland Clinic, University of Erlangen in Germany and University of Oxford in the United Kingdom, the imaging biomarker captures inflammation by mapping spatial changes of perivascular fat attenuation on coronary computed tomography angiography.
